Appili Therapeutics

Appili Therapeutics

Appili Therapeutics is dedicated to identifying, acquiring and advancing novel therapeutics in the area of infectious disease. Appili has commenced development on two antibiotic programs, ATI-1501 and ATI-1503, while continuing our search for additional high quality anti-infective programs suitable for acquisition. 

Area of focus: 
Infectious Diseases & Vaccines
Graduation date: 
01/16/2018
Commencement date: 
01/16/2017

Share